Promoting long term adherence to antiretroviral treatment

BMJ (Online)

Volumn 344, Issue 7865, 2012, Pages

  Mills, Edward J ^a   Lester, Richard ^b   Ford, Nathan ^c  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c MÉDECINS SANS FRONTIÈRES   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ANTIVIRAL THERAPY; DOCTOR PATIENT RELATION; EDITORIAL; FUNDING; HEALTH BEHAVIOR; HEALTH PROMOTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LONG TERM CARE; MEDICAL RESEARCH; MOBILE PHONE; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT MONITORING; PRIORITY JOURNAL; SELF CONCEPT; SOCIAL BEHAVIOR; VACCINATION; VIRUS STRAIN; ZAMBIA;

EID: 84863797983     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e4173     Document Type: Editorial

References (12)

1. Moszynski P. Global fund suspends new projects until 2014 because of lack of funding. BMJ 2011;343:d7755.
2. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011;365:493-505.
3. WHO. Global HIV/AIDS response: epidemic update and health sector progress towards universal access. 2011. www.who.int/hiv/pub/.
4. Mills EJ, Nachega JB, Buchan I, Orbinski J, Attaran A, Singh S, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis. JAMA 2006;296:679-90. (Pubitemid 44200639)
5. Hamers RL, Wallis CL, Kityo C, Siwale M, Mandaliya K, Conradie F, et al. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study. Lancet Infect Dis 2011;11:750-9.
6. Lima VD, Bangsberg DR, Harrigan PR, Deeks SG, Yip B, Hogg RS, et al. Risk of viral failure declines with duration of suppression on highly active antiretroviral therapy irrespective of adherence level. J Acquir Immune Defic Syndr 2010, 55:460-5.
7. Barnighausen T, Chaiyachati K, Chimbindi N, Peoples A, Haberer J, Newell ML. Interventions to increase antiretroviral adherence in sub-Saharan Africa: a systematic review of evaluation studies. Lancet Infect Dis 2011;11:942-51.
8. Kranzer K, Ford N. Unstructured treatment interruption of antiretroviral therapy in clinical practice: a systematic review. Trop Med Int Health 2011; published online 1 July.
9. Ware NC, Idoko J, Kaaya S, Biraro IA, Wyatt MA, Agbaji O, et al. Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med 2009;6:e11.
10. Decroo T, Telfer B, Biot M, Maïkéré J, Dezembro S, Cumba LI, et al. Distribution of antiretroviral treatment through self-forming groups of patients in Tete province, Mozambique. J Acquir Immune Defic Syndr 2010; published online 13 November.
11. Lester RT, Ritvo P, Mills EJ, Kariri A, Karanja S, Chung MH, et al. Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial. Lancet 2010;376:1838-45.
12. Haberer JE, Kahane J, Kigozi I, Emenyonu N, Hunt P, Martin J, et al. Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav 2010;14:1340-6.